National Comprehensive Cancer Network



About NCCN

Pancreatic Adenocarcinoma Panel - Disclosures as of 11/26/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Horacio J. Asbun, MD

       

Pending

Stephen Behrman, MD

None

None

None

None

7/16/2014

Al B. Benson III, MD, FACP, FASCO

Amgen Inc.;
Bayer HealthCare;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Advanced Accelerator Applications SA;
Alchemia;
Astellas;
Aveo;
Gilead;
Infinity

Bayer HealthCare;
Bristol-Myers Squibb Company;
Celgene Corporation;
Eli Lilly and Company;
Genentech, Inc.;
Genomic Health, Inc.;
ImClone Systems Incorporated;
Merck & Co., Inc.;
National Cancer Institute;
Spectrum Pharmaceutics;
Vicus;
Precision Therapeutics, Inc.;
sanofi-aventis U.S.

None

None

9/25/2014

Marian Birkeland, PhD

None

None

None

None

10/7/2014

Jennifer Burns

None

None

None

None

9/24/2014

Charles Cha, MD

None

None

None

None

10/8/2014

E. Gabriela Chiorean, MD

Celgene Corporation;
Genentech, Inc.

Genentech, Inc.

None

None

9/2/2014

Vincent Chung, MD

None

None

None

None

9/8/2014

Steven J. Cohen, MD

Genentech, Inc.

Bristol-Myers Squibb Company;
Genentech, Inc.;
Genentech, Inc.

None

None

10/7/2013

Brian Czito, MD

Abbott Laboratories

Pfizer Inc.

None

None

8/17/2014

Anitra Engebretson

None

None

None

None

10/3/2013

Mary Feng, MD

None

None

None

None

10/4/2013

Deborah Freedman-Cass, PhD

None

None

None

None

9/16/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

9/16/2014

William G. Hawkins, MD

Adura;
Gilead;
New Link Genetics

None

None

None

10/3/2013

Joseph Herman, MD

Nucletron

Celgene Corporation

None

None

9/5/2014

John P. Hoffman, MD

None

None

None

None

8/22/2014

Andrew H. Ko, MD

Celgene Corporation;
Genentech, Inc.;
ImClone Systems Incorporated;
Aduro Biosciences;
InCyte;
Infinity Pharmaceuticals;
OncoGenex;
Prism

Merrimack

None

None

8/15/2014

Srinadh Komanduri, MD

None

None

None

None

1/23/2014

Albert Koong, MD, PhD

Varian Medical Systems, Inc.

Varian Medical Systems, Inc.

None

None

10/3/2013

Andrew M. Lowy, MD

Halozyme Therapeutics

Merck & Co., Inc.;
;
Bexion Inc

None

None

8/15/2014

Wen Wee Ma, MD

Novartis Pharmaceuticals Corporation;
EMD Serono;
Halozyme Therapeutics;
Kinex Pharmaceuticals;
Onconova Therapeutics;
SunPharma Research

None

None

None

9/9/2014

Mokenge P. Malafa, MD, FACS

None

None

None

None

8/28/2014

Joan S. McClure, MS

None

None

None

None

6/20/2014

Nipun B. Merchant, MD

None

None

None

None

1/23/2014

Sean J. Mulvihill, MD

National Cancer Institute

Myriad Genetic Laboratories, Inc.

None

None

9/9/2014

Peter Muscarella II, MD

GlobeImmune;
Stryker

None

None

None

7/9/2014

Eric K. Nakakura, MD

None

None

None

None

6/26/2014

Eileen M. O'Reilly, MD

Celgene Corporation;
OncoMed Pharmaceuticals;
Aduro;
Incyte;
Momemta;
Polaris;
sanofi-aventis U.S.

Celgene Corporation;
silenseed;
Pharmacyclics;
sanofi-aventis U.S.

None

None

6/27/2014

Jorge Obando, MD

None

Merck & Co., Inc.

None

None

10/7/2013

Martha B. Pitman, MD

None

None

None

None

1/2/2014

Donna Powell, MS, CMD, RT(T)

None

None

None

None

10/1/2014

Sushanth Reddy, MD

None

None

None

None

7/8/2014

Aaron R. Sasson, MD

None

Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

1/10/2014

Margaret A. Tempero, MD

Bayer HealthCare

AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Boehringer Ingelheim GmbH;
Celgene Corporation;
Covidien AG;
Genentech, Inc.;
Myriad Genetic Laboratories, Inc.;
Asuragen;
Bionomics;
NuCana BioMed;
Peregrine;
Quest Diagnostic

None

Celgene Corporation

2/24/2014

Sarika Trikha, PharmD

None

None

None

None

11/11/2014

Colin D Weekes, MD, PhD

Amgen Inc.;
Bayer HealthCare;
Celgene Corporation;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
OncoMed Pharmaceuticals;
Abbvie

Celgene Corporation;
Merrimack

None

None

9/2/2014

Robert A. Wolff, MD

None

Precision Medicine Research Associates (PMRA)

McGraw-Hill

Clovis Oncology - Rucaparib Pancreatic Advisory Board;
London Health Science Centre Surgical Grand Rounds

7/17/2014

Brian M. Wolpin, MD, MPH

None

None

None

None

11/17/2014